Picture of Mauna Kea Technologies SA logo

ALMKT Mauna Kea Technologies SA Share Price

0.000.00%
fr flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Momentum

Relative Strength (%)
1m-5.41%
3m-22.83%
6m-28.58%
1yr-35.04%
Volume Change (%)
10d/3m+5.16%
Price vs... (%)
52w High-49.55%
50d MA-4.65%
200d MA-20.01%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)3.68
PEG Ratio (f)n/a
EPS Growth (f)n/a
Dividend Yield (f)n/a
Valuation (ttm)IndustryMarket
Price to Book Valuen/a
Price to Tang. Bookn/a
Price to Free Cashflow146.22
Price to Sales1.73
EV to EBITDA9.98

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital26.09%
Return on Equityn/a
Operating Margin24.09%

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202331st Dec 2024
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2023 / 2024

Blurred out image of Mauna Kea Technologies SA EPS forecast chart

Profile Summary

Mauna Kea Technologies SA formerly Mauna Kea Technologies SAS is a medical device company based in France. The Company specializes in designing, developing, and selling optical biopsy devices and tools. Its products are intended for visualizing and detecting cellular abnormalities during the gastrointestinal and pulmonary endoscopic procedures, primarily in cancer patients. It provides Cellvizio product that is used by medical specialties and is revolutionizing the way physicians diagnose and treat patients making a transformative change in medicine. Its real-time in vivo cellular imaging platform, that delivers in vivo cellular visualization which enables physicians to monitor the progression of disease over time.

Directors

Last Annual
December 31st, 2022
Last Interim
June 30th, 2023
Incorporated
April 21st, 2000
Public Since
July 5th, 2011
No. of Employees
67
Sector
Healthcare Equipment & Supplies
Industry
Healthcare
Exchange
fr flag iconEuronext - Paris
Shares in Issue
48,365,498

ALMKT Share Price Performance

Upcoming Events for ALMKT

Mauna Kea Technologies SA Annual Shareholders Meeting

Q2 2024 Mauna Kea Technologies SA Trading Statement Release

Half Year 2024 Mauna Kea Technologies SA Earnings Release

Q3 2024 Mauna Kea Technologies SA Trading Statement Release

Similar to ALMKT

Picture of AbL Diagnostics SA logo

AbL Diagnostics SA

fr flag iconEuronext - Paris

Picture of Affluent Medical SAS logo

Affluent Medical SAS

fr flag iconEuronext - Paris

Picture of Alpha MOS SA logo

Alpha MOS SA

fr flag iconEuronext - Paris

Picture of Amplitude Surgical SA logo

Amplitude Surgical SA

fr flag iconEuronext - Paris

Picture of Biomerieux SA logo

Biomerieux SA

fr flag iconEuronext - Paris

FAQ